|
Outcomes— no. (%)
|
Control
|
p value
|
Diabetes
|
p value
|
|---|
|
Q1
|
Q2
|
Q3
|
Q4
|
Q1
|
Q2
|
Q3
|
Q4
|
|---|
|
Primary outcome
|
|
Death
|
2 (1.0)
|
3 (1.6)
|
5 (2.6)
|
9 (4.7)
|
0.10
|
6 (3.1)
|
12 (6.2)
|
13 (6.8)
|
25 (13.0)
|
0.002
|
|
Secondary outcomes
|
| |
7 (3.6)
|
10 (5.2)
|
10 (5.2)
|
17 (8.9)
|
0.16
|
20 (10.4)
|
21 (10.9)
|
18 (9.4)
|
32 (16.7)
|
0.11
|
|
CVD death
|
1 (0.5)
|
1 (0.5)
|
2 (1.0)
|
6 (3.1)
|
0.08
|
3 (1.6)
|
9 (4.7)
|
6 (3.1)
|
13 (6.8)
|
0.06
|
|
MI
|
1 (0.5)
|
2 (1.0)
|
0 (0)
|
7 (3.6)
|
0.01
|
3 (1.6)
|
6 (3.1)
|
4 (2.1)
|
11 (5.7)
|
0.09
|
|
Stroke
|
3 (1.6)
|
7 (3.6)
|
7 (3.6)
|
6 (3.1)
|
0.59
|
12 (6.3)
|
8 (4.1)
|
6 (3.1)
|
8 (4.1)
|
0.50
|
|
HF
|
1 (0.5)
|
1 (0.5)
|
0 (0)
|
1 (0.5)
|
0.80
|
4 (2.1)
|
2 (1.0)
|
2 (1.0)
|
4 (2.1)
|
0.71
|
|
Renal dysfunction
|
2 (1.0)
|
0 (0)
|
2 (1.0)
|
3 (1.6)
|
0.43
|
1 (0.5)
|
4 (2.1)
|
5 (2.6)
|
13 (6.8)
|
0.003
|
- CVD cardiovascular disease, MI myocardial infarction, HF hospitalization for heart failure
